China Pharma Holdings (CPHI) Interest Coverage Ratio Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -58.34% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -14.91% |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | -161.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -161.95% |
| Sep 30, 2025 | 94.11% |
| Jun 30, 2025 | 52.83% |
| Mar 31, 2025 | 32.26% |
| Sep 30, 2024 | -157,419.40% |
| Jun 30, 2024 | -1,984.23% |
| Mar 31, 2024 | -698.56% |
| Dec 31, 2023 | 296.31% |
| Sep 30, 2023 | 99.90% |
| Jun 30, 2023 | -118.29% |
| Mar 31, 2023 | -19.76% |
| Dec 31, 2022 | -760.90% |
| Sep 30, 2022 | -127,837.18% |
| Jun 30, 2022 | 68,238.23% |
| Mar 31, 2022 | -16,492.70% |
| Dec 31, 2021 | 74.76% |
| Sep 30, 2021 | 10.88% |
| Jun 30, 2021 | -1,180.03% |
| Mar 31, 2021 | -27.98% |
| Dec 31, 2020 | -113.37% |